News | August 24, 2025
Akums Drugs and Pharmaceuticals signs framework agreement with Govt. of Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
This project shall be implemented through incorporation of a new joint venture company in Zambia
The facility will be positioned as a Centre of Excellence for tertiary care services
Fourteenth breakthrough therapy designation granted by FDA across the oncology portfolio of Daiichi Sankyo
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
For patients with resectable early-stage gastric and gastroesophageal junction cancers
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival - three times longer than R-GemOx
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
Subscribe To Our Newsletter & Stay Updated
